Top
Skip to Content
LOGO(small) - Queen's University Belfast
  • Our twitter
  • Our facebook
  • Our
  • Our
LOGO(large) - Queen's University Belfast

The Patrick G Johnston Centre for Cancer Research

  • Home
  • Our Science
    • Tumour Specialisms and Clinical Trials
    • Disciplinary Strengths
    • Technology Specialisms
    • Major Research Programmes
  • Education
    • Clinical Academic Training
    • Postgraduate Research
    • Postgraduate Taught
    • Princess Margaret Cancer Centre
    • Summer Research Programme
    • Undergraduate
  • Impact
    • Videos
    • Seminars and Events
    • Research Engagement
    • Industry and Innovations
    • Bulletins and Annual Reports
  • Cancer Digest
    • Blood Cancer
    • Breast Cancer
    • Digital Pathology
    • Prostate Cancer
    • Radiotherapy
    • Bowel Cancer
  • Opportunities
    • Academic Posts
    • Postdoctoral
    • PhD Opportunities
  • Contact Us
    • Academic Staff
    • Administrative Staff
    • Clinical Academic Training Programme
    • Clinical Research Fellows
    • Honorary Staff
    • Research Staff
    • Technical Staff
  • News
  • Donate
  • Home
  • Our Science
    • Tumour Specialisms and Clinical Trials
    • Disciplinary Strengths
    • Technology Specialisms
    • Major Research Programmes
  • Education
    • Clinical Academic Training
    • Postgraduate Research
    • Postgraduate Taught
    • Princess Margaret Cancer Centre
    • Summer Research Programme
    • Undergraduate
  • Impact
    • Videos
    • Seminars and Events
    • Research Engagement
    • Industry and Innovations
    • Bulletins and Annual Reports
  • Cancer Digest
    • Blood Cancer
    • Breast Cancer
    • Digital Pathology
    • Prostate Cancer
    • Radiotherapy
    • Bowel Cancer
  • Opportunities
    • Academic Posts
    • Postdoctoral
    • PhD Opportunities
  • Contact Us
    • Academic Staff
    • Administrative Staff
    • Clinical Academic Training Programme
    • Clinical Research Fellows
    • Honorary Staff
    • Research Staff
    • Technical Staff
  • News
  • Donate
  • Our twitter
  • Our facebook
  • Our
In This Section

  • Home
  • The Patrick G Johnston Centre for Cancer Research
  • News

News

QUEEN'S RESEARCHERS DEVELOP NEW TREATMENT FOR PANCREATIC CANCER

21 May, 2018

Queen’s researchers have secured a prestigious award to develop a new antibody drug for the treatment of pancreatic cancer.

Queen’s University Belfast researchers at the Centre for Cancer Research and Cell Biology (CCRCB) alongside local company Fusion Antibodies plc have secured a prestigious Medical Research Council (MRC) award to develop a new antibody drug for the treatment of pancreatic cancer.

Globally pancreatic cancer is still one of the most difficult cancers to treat, and new treatments are urgently required.

Recent statistics from Cancer Research UK shows that in the UK alone, almost 10,000 new cases are detected annually and the outlook for patients is much poorer than those suffering other cancers. 

Queen’s researchers are addressing this gap by designing an antibody that specifically targets the surface of the cancer cells.

Professor Dan Longley, Chair of Molecular Oncology at the Centre for Cancer Reserach Cell Biology (CCRCB) explains that, “this approach, called immunotherapy, has been heralded as a game-changing approach for other cancers such as skin melanomas, but new innovations are required to treat pancreatic cancer and this is the focus of our current work.”

To create these antibodies the Queen’s team will work with therapeutic antibody development specialists Fusion Antibodies plc to develop these prototype molecules.

Explaining the concept behind this new award, Professor Chris Scott, Chair of Pharmaceutical Biosciences at CCRCB at Queen’s University describes, “Pancreatic cancer is the 6th most common cause of cancer death in the UK.

“Our aim is to develop a new antibody drug that will re-arm and trigger the patients’ own immune systems to combat the disease.   This exciting project is very much in line with the research ethos of Queen's University, which is centred on Global Challenges.  With this discovery, we hope to change the lives of people across the world who are diagnosed with pancreatic cancer.”

Dr Paul Kerr, Chief Executive at Fusion Antibodies said, “We are delighted to use our expertise in drug development and antibody engineering to collaborate with Queen’s University to generate new drug candidates for pancreatic cancer."

This current project builds on a successful research programme funded by the Northern Ireland Health and Social Care Research & Development Division.

The research team are kindly supported by generous donations through the Queen’s University of Belfast Foundation into pancreatic research. 

Media

Media inquiries to Sian Devlin at Queen’s Communications Office on: s.devlin@qub.ac.uk or tel:028 9097 5292. 

Share
Latest News
  • Taoiseach Micheál Martin's visit to PGJCCR
    8 October, 2021
  • Queen’s Researchers pioneer potentially life-changing oesophageal cancer test
    18 April, 2020
  • BREAKING DOWN THE DATA SILOS TO CREATE A "DATA TRANSLATOR" FOR ENHANCED CANCER CARE
    9 April, 2020
  • The work experience day on Wednesday 18th March 2020 is now fully booked.
    27 January, 2020
  • Dr Karl Butterworth receives prestige Michael Fry Research Award
    30 May, 2019
Home
  • Home
  • Our Science
  • Education
  • Impact
  • Cancer Digest
  • Opportunities
  • Contact Us
  • News
  • Donate
Queen's University Belfast - Logo (small)
Contact Us

The Patrick G Johnston Centre for Cancer Research

Queen's University Belfast
97 Lisburn Road
Belfast
BT9 7AE

Phone: +44 (0) 28 9097 2760
Email: pgjccr@qub.ac.uk  
Fax: +44 (0) 28 9097 2776

Quick Links

  • Home
  • Our Science
  • Education

 

© Queen's University Belfast 2023
Privacy and cookies
Website accessibility
Freedom of information
Modern slavery statement
Equality, Diversity and Inclusion
Manage cookies